Omkar Pharmachem Share Price
Small Cap | Chemicals | BSE: 532167
₹30.00 
0.00 (0.00 %)
Last Updated: 03 Feb 2025 12:00 AM
BEARISH
Overview
Open (₹) 30.00
High (₹) 30.00
Low (₹) 30.00
Prev. Close (₹) 30.00
Volume 113
VWAP (₹) 30.00
ROCE (%) 3.05
Industry P/E 58.30
TTM P/E 150.00
P/B Ratio 3.28
Market Cap (₹) Cr.30.25
Dividend Yield (%)--
EPS (₹) 0.19
ROE2.07%
Sales Growth (%) --
Profit Growth (%)-4.4
Day Range
30.0030.00
52 Week Range
21.5030.00
Historical Returns
Returns (6M)
11.36 %
Returns (1Y)
33.45 %
Returns (3Y)
28.21 %
Returns (5Y)
88.68 %
Returns (6M)
11.36 %
Returns (1Y)
33.45 %
Returns (3Y)
28.21 %
Returns (5Y)
88.68 %
SWOT Analysis
Technicals
Technical Rating
BEARISHRSI 56.59
MFI 15.55
ATR 0.52
Commodity Channel Index 98.24
ROC125 52.28
ROC21 30.43
Williams %R N/A
Resistance & Support
| Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
|---|---|---|---|---|---|---|---|
| Current | 30.00 | 30.00 | 30.00 | 30.00 | 30.00 | 30.00 | 30.00 |
| Week Ago | 30.00 | 30.00 | 30.00 | 30.00 | 30.00 | 30.00 | 30.00 |
EMA & SMA
30.00
Current Price
Bullish Moving Averages
18
Bearish Moving Averages
0
5 Day 30.00
9 Day 29.10
10 Day 28.69
12 Day 28.64
14 Day 28.59
20 Day 27.15
26 Day 26.22
50 Day 24.11
100 Day 23.15
200 Day N/A
Deals & Announcements
Bulk and Block Deals
Insider Trading
Corporate Actions
No corporate actions available.
Announcements
| Date | Source | Detail |
|---|---|---|
| 14 Feb, 2025 | BSE India | Dear Sir, \r\nPlease find attached Integrated Filing- Financials for Quarter ended December 31, 2024. |
| 14 Feb, 2025 | BSE India | Dear Sir, \r\nPlease find attached herewith Unaudited Financial Results for the Quarter ended 31 December 2024. |
| 14 Feb, 2025 | BSE India | Dear Sir, Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015, please note that the Board in their meeting held on 14th February, 2025 has considered and approved the unaudited Financial Results of the Companyand Limited Review Report for the Quarter ended on 31.12.2024. |
| 06 Feb, 2025 | BSE India | OMKAR PHARMACHEM LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 ,inter alia, to consider and approve OMKAR PHARMACHEM LTD. has informed BSE that the meeting of the Board of Directors of the Company has been scheduled on 14/02/2025 ,inter alia, to consider and approve the unaudited financial results of the company for Quarter ended on 31st December 2024. |
| 18 Jan, 2025 | BSE India | Dear Sir/Madam, \r\nPursuant to Regulation 30 and other applicable provisions of the Listing Regulations, we hereby inform that based on the recommendation of the Nomination and Remuneration Committee, the Board of Directors of the Company, at its meeting held today viz. Saturday, January 18th, 2025, approved the appointment of Mr. Pankaj Mahadeo Singh as Company Secretary and Compliance Officer w.e.f. January 18th, 2025. |
| 26 Dec, 2024 | BSE India | Dear Sir,\r\nPlease find attached the resignation of Company Secretary and Compliance Officer of the Company. |
| 12 Nov, 2024 | BSE India | Dear Sir,\r\nPlease find attached herewith unaudited financial results for the quarter and half year ended on September 30, 2024 |
| 12 Nov, 2024 | BSE India | Dear Sir, Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015, please note that the Board in their meeting held on 12th November, 2024 has considered and approved the following business: Unaudited Financial Results of the Company along with Statement of Assets and Liabilities, Cash Flow Statement and Limited Review Report for the Quarter and half year ended on 30th September, 2024. |
| 05 Nov, 2024 | BSE India | OMKAR PHARMACHEM LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2024 ,inter alia, to consider and approve OMKAR PHARMACHEM LTD. has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2024 ,inter alia, to consider and approve Unaudited financial results of the company for Quarter and half year ended on 30th September 2024 |
| 10 Oct, 2024 | BSE India | Dear Sir,\r\nPlease find Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended on 30th September, 2024 |
Board Meetings
| Purpose | Details | Meeting Date | Broadcast Date |
|---|---|---|---|
| Quarterly Results | -- | 07 Feb, 2025 | 14 Feb, 2025 |
| Quarterly Results | -- | 06 Nov, 2024 | 12 Nov, 2024 |
| Quarterly Results | -- | 06 Aug, 2024 | 12 Aug, 2024 |
| Audited Results | -- | 23 May, 2024 | 30 May, 2024 |
| Quarterly Results | -- | 07 Feb, 2024 | 14 Feb, 2024 |
| Quarterly Results | -- | 03 Nov, 2023 | 10 Nov, 2023 |
| Quarterly Results | -- | 07 Aug, 2023 | 14 Aug, 2023 |
| Audited Results | -- | 24 May, 2023 | 30 May, 2023 |
| Quarterly Results | -- | 07 Feb, 2023 | 14 Feb, 2023 |
| Quarterly Results | -- | 07 Nov, 2022 | 14 Nov, 2022 |
Share Holding Pattern
| Owner Name | Sept, 2024 | Jun, 2024 | Mar, 2024 | Dec, 2023 | Sept, 2023 |
|---|
About Omkar Pharmachem
Omkar Pharmachem is a Public Limited Listed company incorporated on 31/03/1995 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L93000GJ1995PLC025276 and registration number is 025276. Currently Company is involved in the business activities of Other business support service activities. Company’s Total Operating Revenue is Rs. 0.54 Cr. and Equity Capital is Rs. 10.08 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Not Applicable
Founded
1995
Managing Director
Mr. Bhawani Shankar Goyal
NSE Symbol
--
Omkar Pharmachem Management
| Name | Designation |
|---|---|
| Mr. Bhawani Shankar Goyal | Managing Director |
| Ms. Mamta Pachori | Independent Director |
| Mr. Janak Raj Sharma | Independent Director |
| Mr. Parminder Sharma | Director |
Peer Comparison
| Stocks | Market Cap | Market Price | 52 Week Low-High |
|---|---|---|---|
| SRF | ₹67,123.92 | ₹2,759.35  ₹2,778.90(-0.70%) | ₹2,088.550 - ₹2,697.450 |
| Navin Fluori | ₹16,426.00 | ₹3,911.10 ₹4,033.90(-3.04%) | ₹2,876.450 - ₹3,892.800 |
| Jubilant Ind | ₹2,461.21 | ₹1,633.50 ₹1,633.50(0.00%) | ₹535.000 - ₹1,933.950 |
| Yasho Indust | ₹2,297.28 | ₹1,764.50 ₹1,796.80(-1.80%) | ₹1,514.050 - ₹2,418.000 |
| AndhraSugars | ₹1,273.49 | ₹77.18 ₹79.32(-2.70%) | ₹90.600 - ₹128.960 |
FAQs on Omkar Pharmachem
What is the share price of Omkar Pharmachem?
The share price of Omkar Pharmachem on 03 Feb, 2025 is ₹ 30.00.
What is 52W high and 52W low share price of Omkar Pharmachem?
The highest and lowest 52W share prices of Omkar Pharmachem are ₹ 28.990 and ₹ 20.750
What is the market cap of Omkar Pharmachem?
The market capitalization of Omkar Pharmachem as of 03 Feb, 2025 is ₹ 30.25 Crores
What is the P/E ratio of Omkar Pharmachem?
The current P/E ratio of Omkar Pharmachem as of 03 Feb, 2025 is 58.30
What is the PB ratio of Omkar Pharmachem?
The PB ratio of Omkar Pharmachem as of 03 Feb, 2025 is 3.28
Top Gainers
948IHFL26I
IBHFL NCD186
₹845.00
₹705.00 (0.20%)
GREAVESCOT
Greaves
₹281.85
₹234.90 (0.20%)
ASHSI
Ashirwd Stl
₹45.66
₹38.05 (0.20%)
CAPRO
Caprola.Chem
₹62.40
₹52.00 (0.20%)
Top Losers
DHANBANK
Dhanalak.Bnk
₹32.19
₹35.97 (-0.11%)
08MPD
08MPD
₹8.66
₹9.62 (-0.10%)
BALTE
BalurghtTran
₹27.13
₹31.24 (-0.13%)
DARSHANORNA
Darshan Orna
₹4.57
₹5.07 (-0.10%)
Market Indices
Sensex
₹78,699.07
₹78,472.48 (0.00%)